Follow

Amniotics AB

Nasdaq First North GM (Sweden)

Amniotics AB developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient.

Sector:
HEALTH CARE
>
Biotechnology
IPO
Price
20.50 SEK
Subscription period
15 Jun - 29 Jun 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
AMNI
SE0015961016
Nasdaq First North GM
Sweden (SE)
Details of share in Amniotics AB with ticker AMNI
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
First trading date
06 Jul 2021
Type
Price
Pre-money
Time
Files
IPO
20.50 SEK
265.17M SEK
15 Jun - 29 Jun 2021
IPO in Amniotics AB
Type
Ticker
ISIN
Market
OPTION
AMNI TO1
SE0016101471
Nasdaq First North GM
Sweden (SE)
Details of option in Amniotics AB with ticker AMNI TO1
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
06 Jul 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 23.50.
Type
Price
Pre-money
Time
Files
Exercise
23.50 SEK
05 May - 19 May 2022
Option exercise terms for AMNI TO1
People
Kåre Engkilde
CEO
Christopher Andrew Bravery
Board member
Peter Buhl
Board member
Lars Stigsson
Board member
Ingrid Atteryd Heiman
Board member
Fredrik Tiberg
Board member
Christer Fåhraeus
Board member
Anders Månsson
Board member
Marcus Kåre Torleif Larsson
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 2
Zip code
223 63
City/district
Lund
Country
Sweden (SE)
Registration number
559024-6558
LEI code
5493003DIB84XBK6ZQ87
First trade date
06 Jul 2021
Registration date
01 Sep 2015
Short name
Amniotics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More